- Management of patients with intermediate-risk early stage cervical cancer
-
Cibula D
- KMID: 2500486
- J Gynecol Oncol.
- 2020 Apr;31(3):e54.
- doi: 10.3802/jgo.2020.31.e54
-
- CITED
-
- Close
- SHARE
-
- Close
- Management of ovarian cancer patients in affected areas during COVID-19 pandemic: Japan and Korea
-
Kobayashi , Suh DH, Aoki D, Kim JW
- KMID: 2500490
- J Gynecol Oncol.
- 2020 Apr;31(3):e65.
- doi: 10.3802/jgo.2020.31.e65
-
- CITED
-
- Close
- SHARE
-
- Close
- Major clinical research advances in gynecologic cancer in 2019
-
Kim M, Suh DH, Lee KH, Eom KY, Lee JY, Lee YY, Hansen HF, Mirza MR, Kim JW
- KMID: 2500484
- J Gynecol Oncol.
- 2020 Apr;31(3):e48.
- doi: 10.3802/jgo.2020.31.e48
In 2019, 12 topics were selected as the major research advances in gynecologic oncology. Herein, we first opted to introduce the significant clinical activity of pembrolizumab in women with advanced... -
- CITED
-
- Close
- SHARE
-
- Close
- Chemoradiotherapy is not superior to radiotherapy alone after radical surgery for cervical cancer patients with intermediate-risk factor
-
Kim H, Park W, Kim YS, Kim YJ
- KMID: 2500483
- J Gynecol Oncol.
- 2020 Apr;31(3):e35.
- doi: 10.3802/jgo.2020.31.e35
Objectives: There is no consensus on whether giving adjuvant concurrent chemoradiotherapy (CCRT) is more effective than adjuvant radiotherapy (RT) alone in patients with early stage cervical cancer and intermediate-risk factor(s).... -
- CITED
-
- Close
- SHARE
-
- Close
- A phase II trial of cytoreductive surgery combined with niraparib maintenance in platinum-sensitive, secondary recurrent ovarian cancer: SGOG SOC-3 study
-
Shi T, Yin S, Zhu J, Zhang P, Liu J, Xiang L, Zhu Y, Wu S, Chen X, Wang X, Teng Y, Zhu T, Yu A, Zhang Y, Feng Y, Huang H, Bao W, Li Y, Jiang W, Zhang P, Li J, Ai Z, Zhang W, Jia H, Zhang Y, Jiang R, Zhang J, Gao W, Luan Y, Zang R
- KMID: 2500489
- J Gynecol Oncol.
- 2020 Apr;31(3):e61.
- doi: 10.3802/jgo.2020.31.e61
Background: In China, secondary cytoreductive surgery (SCR) has been widely used in ovarian cancer (OC) over the past two decades. Although Gynecologic Oncology Group-0213 trial did not show its overall... -
- CITED
-
- Close
- SHARE
-
- Close
- Characterizing the efficacy and trends of adjuvant therapy versus observation in women with early stage (uterine confined) leiomyosarcoma: a National Cancer Database study
-
Costales A, Radeva M, Ricci S
- KMID: 2500475
- J Gynecol Oncol.
- 2020 Apr;31(3):e21.
- doi: 10.3802/jgo.2020.31.e21
Objective: The utility of adjuvant therapy for women with uterine confined leiomyosarcoma remains uncertain. We sought to identify trends, analyze efficacy, and assess survival impact of adjuvant therapy in this... -
- CITED
-
- Close
- SHARE
-
- Close
- Primary sarcoma of the cervix: an analysis of patient and tumor characteristics, treatment patterns, and outcomes
-
Albert A, Lee A, Allbright , Vijayakumar S
- KMID: 2500477
- J Gynecol Oncol.
- 2020 Apr;31(3):e25.
- doi: 10.3802/jgo.2020.31.e25
Objective: Primary sarcoma of the cervix is rare and is associated with worse outcomes as compared to other histologies. The purpose of this study was to identify national treatment patterns... -
- CITED
-
- Close
- SHARE
-
- Close
- Robot assisted surgery during the COVID-19 pandemic, especially for gynecological cancer: a statement of the Society of European Robotic Gynaecological Surgery (SERGS)
-
Kimmig R, Verheijen , Rudnicki M, SC
- KMID: 2500488
- J Gynecol Oncol.
- 2020 Apr;31(3):e59.
- doi: 10.3802/jgo.2020.31.e59
All surgery performed in an epicenter of the coronavirus disease 2019 (COVID-19) pandemic, irrespective of the known or suspected severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) status of the patient,... -
- CITED
-
- Close
- SHARE
-
- Close
- Quantitative analysis of proteins related to chemoresistance to paclitaxel and carboplatin in human SiHa cervical cancer cells via iTRAQ
-
He Y, Han SB, Geng YN, Yang SL, Wu YM
- KMID: 2500479
- J Gynecol Oncol.
- 2020 Apr;31(3):e28.
- doi: 10.3802/jgo.2020.31.e28
Objective: This study aimed to identify proteins related to paclitaxel and carboplatin chemoresistance in cervical cancer. Methods: Quantitative proteomic analysis was performed on normal SiHa cells and those treated with paclitaxel... -
- CITED
-
- Close
- SHARE
-
- Close
- Risk factors for early death among ovarian cancer patients: a nationwide cohort study
-
Mosgaard B, Meaidi A, Høgdall C, Noer MC
- KMID: 2500481
- J Gynecol Oncol.
- 2020 Apr;31(3):e30.
- doi: 10.3802/jgo.2020.31.e30
Objective: To characterize ovarian cancer patients who die within 6 months of diagnosis and to identify prognostic factors for these early deaths. Methods: A nationwide cohort study covering ovarian cancer in... -
- CITED
-
- Close
- SHARE
-
- Close
- BRCA1/2 mutation status in patients with metachronous breast and ovarian malignancies: clues towards the implementation of genetic counseling
-
Chao A, Lin YH, Yang LY, Wu RC, Chang WY, Chang PY, Chang SC, Lin CY, Huang HJ, Lin CT, Chou HH, Huang KG, Kuo WL, Chang TC, Lai CH
- KMID: 2500476
- J Gynecol Oncol.
- 2020 Apr;31(3):e24.
- doi: 10.3802/jgo.2020.31.e24
Objective: The characteristics of patients with metachronous breast and ovarian malignancies and the pathogenic role of BRCA1/2 mutations remain poorly understood. We investigated these issues through a review of hospital... -
- CITED
-
- Close
- SHARE
-
- Close
- Prognostic significance of lymphovascular space invasion in patients with endometrioid endometrial cancer: a retrospective study from a single center
-
Dai Y, Dong Y, Cheng Y, Hou H, Wang J, Wang Z, Wang J
- KMID: 2500478
- J Gynecol Oncol.
- 2020 Apr;31(3):e27.
- doi: 10.3802/jgo.2020.31.e27
Objective: This study aims to analyze factors associated with lymphovascular space invasion (LVSI) and evaluate the prognostic significance of LVSI in Chinese endometrioid endometrial cancer (EEC) patients. Methods: Five-hundred eighty-four EEC... -
- CITED
-
- Close
- SHARE
-
- Close
- Sensitizing endometrial cancer to ionizing radiation by multi-tyrosine kinase inhibition
-
Wang E, Sorolla A
- KMID: 2500480
- J Gynecol Oncol.
- 2020 Apr;31(3):e29.
- doi: 10.3802/jgo.2020.31.e29
Objective: Endometrial carcinoma is the most frequent gynecological cancer. About 15% of these cancers are of high risk and radiotherapy still remains the most suitable treatment. In this context, agents... -
- CITED
-
- Close
- SHARE
-
- Close
- Nerve-sparing radical hysterectomy in the precision surgery for cervical cancer
-
Sakuragi N, Murakami G, Konno Y, Kaneuchi M, Watari H
- KMID: 2500485
- J Gynecol Oncol.
- 2020 Apr;31(3):e49.
- doi: 10.3802/jgo.2020.31.e49
Precision cancer surgery is a system that integrates the accurate evaluation of tumor extension and aggressiveness, precise surgical maneuvers, prognosis evaluation, and prevention of the deterioration of quality of life... -
- CITED
-
- Close
- SHARE
-
- Close
- National screening programs for cervical cancer in Asian countries
-
Aoki ES, Yin R, Li K, Bhatla N, Singhal S, Ocviyanti , Saika K, Suh M, Kim M, Termrungruanglert W
- KMID: 2500487
- J Gynecol Oncol.
- 2020 Apr;31(3):e55.
- doi: 10.3802/jgo.2020.31.e55
Cervical cancer is still one of the most common female cancers in Asia and the leading cause of cancer-related deaths in low- and middle-income countries. Nowadays, national screening programs for... -
- CITED
-
- Close
- SHARE
-
- Close
- Microscopic diseases remain in initial disseminated sites after neoadjuvant chemotherapy for stage III/IV ovarian, tubal, and primary peritoneal cancer
-
Tate S, Nishikimi , Kato K, Matsuoka A, Kambe M, Kiyokawa T, Shozu M
- KMID: 2500482
- J Gynecol Oncol.
- 2020 Apr;31(3):e34.
- doi: 10.3802/jgo.2020.31.e34
Objective: This study aimed to evaluate the presence of pathological residual tumor (pRT) in each initial disseminated site after neoadjuvant chemotherapy (NACT) to assess the appropriate surgical margins during interval... -
- CITED
-
- Close
- SHARE
-
- Close
